Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer
- 28 March 2014
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (7) , 6425-6434
Abstract
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related deaths among female population worldwide. Metastases are the common cause of morbidity and mortality in breast cancer and can remain latent for several years after surgical removal of the primary tumour. Thus, the identification and functional characterisation of molecular factors that promote oncogenic signalling in mammary tumour development and progression could provide new entry points for designing targeted therapeutic strategies for metastatic breast cancer. In the present study, we investigated the expression of proteins involved in cell signalling (growth hormone receptor (GHR) and NEDD9) and cell-cell adhesion (plakoglobin) in epithelial and stromal compartments of primary ductal invasive breast carcinomas and their axillary lymph node metastases versus non-metastatic tumours. Obtained data revealed remarkable increase in the expression levels of GHR and NEDD9 proteins in both epithelial and stromal components of axillary lymph node metastases in comparison with those of non-metastatic tumours, suggesting that the expression of these two proteins may provide biomarkers for tumour aggressiveness.Keywords
This publication has 33 references indexed in Scilit:
- High Motility of Triple-negative Breast Cancer Cells Is Due to Repression of Plakoglobin Gene by Metastasis Modulator Protein SLUGJournal of Biological Chemistry, 2012
- Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivoBreast Cancer Research, 2012
- Plakoglobin: Role in Tumorigenesis and MetastasisInternational Journal of Cell Biology, 2012
- NEDD9 Is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast CancerPLOS ONE, 2011
- Signaling pathways in breast cancer metastasis - novel insights from functional genomicsBreast Cancer Research, 2011
- Enhanced Genetic Instability and Dasatinib Sensitivity in Mammary Tumor Cells Lacking NEDD9Cancer Research, 2010
- Plakoglobin regulates cell motility through Rho- and fibronectin-dependent Src signalingJournal of Cell Science, 2010
- NEDD9 Promotes Oncogenic Signaling in Mammary Tumor DevelopmentCancer Research, 2009
- Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcomeWorld Journal of Surgical Oncology, 2008
- Pemphigus vulgaris identifies plakoglobin as key suppressor of c‐Myc in the skinThe EMBO Journal, 2006